Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Adverse effects
RCT 3-armed trial	256 people with suspected PCP; 181 people with confirmed diagnoses (only those with confirmed diagnoses were evaluated further)	Rate of adverse effects requiring a change in dose or treatment 19/58 (33%) with clindamycin–primaquine 19/59 (32%) with trimethoprim–dapsone	OR 1.6 95% CI 0.6 to 3.9 P = 0.2 for clindamycin-primaquine v trimethoprim-dapsone		Not significant